CeloxTM Rapid Ribbon brings all the benefits of Celox Rapid Gauze in a 1 inch strip. The low profile pack means Celox Rapid Ribbon is easily concealed and the reduced size makes it ideal for treating narrow entry wounds such as bullet, blast fragment and stab injuries.
The first compact carry minimal compression time gauze for narrow entry wounds.
Celox Rapid considerably reduces treatment time compared to Combat GauzeTM and ChitoGauzeTM, by on average halving the packing time of the competitive 12ft gauzes1 and speeding up compression time2. Independent testing has shown that the reduced treatment time offered by Celox Rapid significantly reduces blood loss in comparison to Combat Gauze3 and evacuation tests have shown that Celox Rapid maintains its volume and adhesion to wet tissue during use, with no re-bleeding and hemostatis maintained during transport.
The chitosan in Celox™ is a specific high quality grade selected for medical use from a shellfish source. Chitosan is made up of glucosamine and N-acetyl glucosamine, which are naturally occurring sugars in the body.
The chitosan in Celox™ is free from animal proteins that would be the cause of any allergic response. It has been tested for allergenic reaction on humans with a known fish or shrimp hypersensitivity and none of the subjects showed any skin reaction to the chitosan(1).
Our products have been through extensive safety and biocompatibility testing to the ISO 10993 standards, the FDA device requirements, and the most stringent class of European Medical Device regulations.
Because Celox™ works independently of the body’s clotting cascade it only works where it directly
touches the blood. It does not set off any thrombotic chain reaction elsewhere that could lead to increased risk of blood clots.
The glucosamine and N-acetyl glucosamine sugars in the chitosan are naturally occurring materials and the body has known metabolic pathways to break down and excrete them(2). This is unlike other hemostats that can leave mineral residuals in the body(3)(4).
Celox™ has had thousands of successful uses since first launched in 2006 with no adverse events reported.